Could a pancreatic peptide hold clues to PCOS-Related insulin resistance?
NCT ID NCT07736079
First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This study looks at whether a hormone called preptin, which is released alongside insulin, is linked to insulin resistance in women with polycystic ovary syndrome (PCOS). Researchers will measure preptin levels in 60 women diagnosed with PCOS and compare them to markers of insulin resistance. The goal is to better understand the metabolic problems that often accompany PCOS.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If preptin is linked to insulin resistance in PCOS, it could point toward a new target for diagnosis or treatment.
- What could go wrong
- This is a small observational study, so it can only show a connection, not prove cause and effect. Results may not apply to all women with PCOS.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a traditional herbal remedy tame type 2 diabetes?
- Can decades of lifting weights keep the Brain's muscle signals young?
- A blood marker may reveal how well diabetes treatments are working
- PCOS may fuel fatty liver in teens even after accounting for obesity — a study investigates
- A sweet drink before heart surgery? trial tests if carbs can ease stress in children
- A fiber supplement may help perimenopausal women — a trial puts it to the test